Narrow band UVB phototherapy in dermatology

Indian Journal of Dermatology, Venereology and Leprology

Volumn 70, Issue 4, 2004, Pages 205-209

  Dogra, Sunil ^a   Kanwar, Amrinder Jit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; DITHRANOL; PSORALEN; TAR; TAZAROTENE;

ATOPIC DERMATITIS; CONTACT DERMATITIS; DISEASE SEVERITY; HUMAN; HYDROA VACCINIFORME; PATIENT SAFETY; PHOTOSENSITIVITY DISORDER; PHOTOTHERAPY; PORPHYRIA CUTANEA TARDA; PRURIGO; PSORIASIS; PUVA; REMISSION; REVIEW; SIDE EFFECT; SKIN DISEASE; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO;

EID: 33646494151     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Fitzpatrick TB, Pathak MA. Historical aspects of methoxsalen and other furocoumarins. J Invest Dermatol 1959;31:229-31.
2. Roelandts R. The history of phototherapy: Something new under the sun? J Am Acad Dermatol 2002;46:926-30.
3. rd Ed. London: Nisbet & Co; 1923-6.
4. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and long-wave ultraviolet light. N Engl J Med 1974;291:1207-11.
5. Wiskemann A. UVB-Phototherapie der Psoriasis mit einer fur die PUVA-Therapie entwickelten Stehbox. Z Hautkr 1978;53:633-6.
6. van Weelden H, De La Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988;119:11-9.
7. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988;119:691-6
8. El-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol 1997;38:99-106.
9. An appraisal of narrow band (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996). Br J Dermatol 1997;137:327-30.
10. Norris DA, Horikawa T, Morelli JG. Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res 1994;7:193-203.
11. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991;97:410-6.
12. Fitzpatrick TB. Mechanisms of phototherapy in vitiligo. Arch Dermatol 1997;133:1591-2.
13. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. psoralen plus UV-A. Arch Dermatol 1997;133:1525-8.
14. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000;42:245-53.
15. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001;44:999-1003.
16. Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002;82:369-72.
17. Dogra S, Parsad D. Combination of narrow band UV-B and topical calcipotriene in vitiligo. Arch Dermatol 2003;139:393.
18. Kanwar AJ, Dogra S, Parsad D, Kumar B. Narrow band UVB for treatment of vitiligo; an emerging effective and well-tolerated therapy. Int J Dermatol (in press).
19. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Arch Dermatol 1998;134:1532-40.
20. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Molec Genet 1997;6:813-20.
21. Bos JD, Hulsebosch HJ, Krieg SR, Bakker PM, Cormane RH. Immunocompetent cells in psoriasis: in situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res 1983;275:181-9.
22. Morganroth GS, Chan LS, Weinstein GD, Voorhees JJ, Cooper KD. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa perivascular dendritic cells. J Invest Dermatol 1991;333-40.
23. Van Weiden H, Baart de la Faille H, Young E, Van der Leun JC. A new development in UVB phototherapy for psoriasis. Br J Dermatol 1988;119:11-9.
24. Fischer T. UV-light treatment of psoriasis. Acta Derm Venereol 1976;56:473-9.
25. Coven TR, Burack LH, Gilleavdeau R, Keogh M, Ozawa M, Krueger JG. Narrow-band UV-B produces superior clinical and histopathological resolution of moderate to severe psoriasis in patients compared with broad band UV-B. Arch Dermatol 1997;133:1514-22.
26. Van Weelden H, Baart de la Faille, Yoong E, Van der Leun JC. Comparison of narrow band UV-B phototherapy and PUVA photochemotherapy (PUVA) in the treatment of psoriasis. Acta Derm Venereol 1990;70:212-5.
27. Kanwar AJ, Dhar S. Severity of atopic dermatitis in India. Br J Dermatol 1994;131:733-4.
28. Hjerppe M, Hasan T, Saksala I, Reunala T. Narrow-band UVB treatment in atopic dermatitis. Acta Derm Venereol 2001;81:439-40.
29. Grundmann-Kollmann M, Behrens S, Podda M, Peter RU, Kaufmann R, Kerscher M. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 1999;40:995-7.
30. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow-band (TL-01) UVB air conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993;128:49-56.
31. Collin P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995;132:956-63.
32. Dogra S, Parsad D, Handa S. Narrowband ultraviolet B in airborne contact dermatitis: a ray of hope! Br J Dermatol 2004;150:373-4.
33. Molin L. Topical calcipotriol combined with phototherapy for psoriasis: the results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group. Dermatology 1999;198:375-81.
34. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001;45:487-98.
35. Mofty ME, Zaher H, Esmat S, Youssef R, Shahin Z, Bassioni D, et al. PUVA and PUVB in vitiligo - are they equally effective? Photodermatol Photoimmunol Photomed 2001;17:159-63.
36. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999;41:51-9.
37. Njoo MD, Westerhof W, Bos JD, Bossuyt MM. The development of guidelines for the treatment of vitiligo. Arch Dermatol 1999;135:1514-21.
38. Slaper H, Schothorst AA. Van der Leun JC. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients. Photodermatology 1986;3:271-83.